A

Aurinia Pharmaceuticals
D

AUPH

9.04000
USD
0.00
(0.00%)
Market Closed
Volume
0
EPS
-0
Div Yield
-
P/E
-60
Market Cap
1,294,340,592
OverviewSignalsIdeasNews
Related Instruments
    A
    ACAD
    0.140
    (0.84%)
    16.880 USD
    B
    BLUE
    -0.69000
    (-7.52%)
    8.49000 USD
    B
    BMRN
    0.695
    (1.07%)
    65.680 USD
    C
    CRSP
    0.360
    (0.89%)
    40.720 USD
    D
    DVAX
    -0.020
    (-0.16%)
    12.720 USD
    E
    EDIT
    -0.01000
    (-0.75%)
    1.32000 USD
    L
    LGND
    1.050
    (0.92%)
    114.800 USD
    R
    RARE
    0.770
    (1.77%)
    44.190 USD
    S
    SRPT
    -0.470
    (-0.39%)
    118.970 USD
    X
    XLRN
    0
    (0%)
    0.000000 USD
    More
News

Title: Aurinia Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.